AZN - Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn refiled
2024-01-19 10:13:55 ET
More on Icosavax
- Icosavax CVR Seems Fairly Valued
- AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition
- Icosavax deal CVR based on FDA approval for IVX-A12, sales in EU, UK, Canada
- Biggest stock movers today: Oracle, Workhorse Group, Icosavax and more
- Seeking Alpha’s Quant Rating on Icosavax
For further details see:
Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn, refiled